Conditioning with Fludarabine-Busulfan versus Busulfan-Cyclophosphamide Is Associated with Lower aGVHD and Higher Survival but More Extensive and Long Standing Bone Marrow Damage

Autor: Yongbin Ye, Yuxian Huang, Jing Wang, Kun-Yuan Guo, Mingwan Zhang, Xin He, Guangyang Weng, Xiaojun Xu
Rok vydání: 2016
Předmět:
0301 basic medicine
Article Subject
T-Lymphocytes
medicine.medical_treatment
lcsh:Medicine
Graft vs Host Disease
Bone Marrow Cells
Hematopoietic stem cell transplantation
General Biochemistry
Genetics and Molecular Biology

Interferon-gamma
Mice
03 medical and health sciences
0302 clinical medicine
hemic and lymphatic diseases
medicine
Splenocyte
Animals
Humans
Transplantation
Homologous

Busulfan
Cyclophosphamide
Bone Marrow Transplantation
General Immunology and Microbiology
business.industry
lcsh:R
Hematopoietic Stem Cell Transplantation
General Medicine
Fludarabine
Transplantation
Disease Models
Animal

Drug Combinations
Regimen
surgical procedures
operative

030104 developmental biology
medicine.anatomical_structure
Gene Expression Regulation
Immunology
Conditioning
Interleukin-4
Bone marrow
business
Vidarabine
Research Article
030215 immunology
medicine.drug
Zdroj: BioMed Research International
BioMed Research International, Vol 2016 (2016)
ISSN: 2314-6141
2314-6133
DOI: 10.1155/2016/3071214
Popis: Acute graft-versus-host disease (aGVHD) is a major complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT) and a major cause of nonrelapse mortality after allo-HSCT. A conditioning regimen plays a pivotal role in the development of aGVHD. To provide a platform for studying aGVHD and evaluating the impact of different conditioning regimens, we established a murine aGVHD model that simulates the clinical situation and can be conditioned with Busulfan-Cyclophosphamide (Bu-Cy) and Fludarabine-Busulfan (Flu-Bu). In our study, BALB/c mice were conditioned with Bu-Cy or Flu-Bu and transplanted with 2×107 bone marrow cells and 2×107 splenocytes from either allogeneic (C57BL/6) or syngeneic (BALB/c) donors. The allogeneic recipients conditioned with Bu-Cy had shorter survivals (P<0.05), more severe clinical manifestations, and higher hepatic and intestinal pathology scores, associated with increased INF-γ expression and diminished IL-4 expression in serum, compared to allogeneic recipients conditioned with Flu-Bu. Moreover, higher donor-derived T-cell infiltration and severely impaired B-cell development were seen in the bone marrow of mice, exhibiting aGVHD and conditioned with Flu-Bu. Our study showed that the conditioning regimen with Bu-Cy resulted in more severe aGVHD while the Flu-Bu regimen was associated with more extensive and long standing bone marrow damage.
Databáze: OpenAIRE